In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Irma Martínez-Flores *Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, México.ORCID 0000-0001-9350-8978 Patricia Bustos *Centro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, México.ORCID 0000-0002-6924-8747 Rosa I SantamaríaCentro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, México.ORCID 0000-0001-6970-7336 Alan Aguayo-GonzálezCentro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, México.ORCID 0009-0000-8925-2164 Eugenia Silva-HerzogUnidad de Vinculación Científica, Facultad de Medicina UNAM en Instituto Nacional de Medicina Genómica (INMEGEN), Ciudad de México, México.ORCID 0000-0001-5620-8722 Xavier SoberónInstituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, México.ORCID 0000-0002-4498-5628 Víctor GonzálezCentro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, México.ORCID 0000-0003-4082-0022 Roberto Cabrera-ContrerasLaboratorio de Patogenicidad Bacteriana, Departamento de Salud Pública, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.ORCID 0000-0001-6734-1967 Funding
Programa de Apoyos a Proyectos de Investigación e Innovación Tecnológica (PAPIIT-UNAM) IN214019
6 · The paper itselfAbstract
Methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) IMPORTANCE: MRSA and MSSA
Indexed as
Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsStaphylococcus aureusAdultAnti-Bacterial AgentsCross InfectionGenome, BacterialGenomicsHumansInfant, NewbornMexicoMicrobial Sensitivity TestsVirulenceVirulence FactorsWhole Genome SequencingAnti-Bacterial AgentsVirulence Factorsantibiotic resistanceclonal transmissioncomparative genomicsgenotypingMRSAMSSAStaphylococcus aureusvirulencewhole-genome sequencing
Identifiers
PMID41842726
PMCPMC13055256
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390